A simplified way of making BRCA mutation testing available for women with ovarian cancer (OC) – a handier procedure that makes results available quicker, pioneered by researchers at the Institute of Cancer Research in London – comes just as competition heats up among drug developers. Read More
A strong development pipeline for regenerative medicine (RM) therapies designed to treat a range of unmet medical needs suggests the potential for rapid growth in global sales of products that could offer significant benefits to public health, according to an analysis by the Tufts Center for the Study of Drug Development (CSDD). Read More
Recognizing opioid addiction as a disease to be treated rather than a crime to be punished, the U.S. Senate overwhelmingly passed the final version of the Comprehensive Addiction and Recovery Act (CARA) Wednesday on a vote of 92-2, sending it to the president for his signature. Read More
HONG KONG – China's multibillion-dollar precision medicine initiative is shaping up with a nearly ¥642 million (US$96 million) investment for 61 key projects ready to go. Read More
Galena Biopharma Inc., of San Ramon, Calif., closed its registered direct offering of 28 million common shares to undisclosed institutional investors. Read More
Eisai Inc., of Woodcliff Lake, N.J., and Arena Pharmaceuticals Inc., of San Diego, said Mexican regulators granted approval of weight management drug Venespri (lorcaserin HCl) for commercialization, by Eisai Laboratorios S. de R.L. de C.V., as an adjunct to a reduced-calorie diet and increased physical activity in adults with a body mass index of 30 kg/m2 or greater. Read More
Beyondspring Pharmaceuticals Inc., of New York, said the FDA notified the company that the phase I/II study with Opdivo (nivolumab, Bristol-Myers Squibb Co.) in combination with plinabulin for patients with metastatic non-small-cell lung cancer may proceed with enrolling patients. Read More
